Showing results (511-520 of 3,348) with videos related to

Sort By:
Pageof 335
Pharmacoeconomics|November 14, 2009
Willingness to pay for a QALY based on community member and patient preferences for temporary health states associated with herpes zosterTracy A Lieu, G Thomas Ray, Ismael R Ortega-Sanchez, et al.
Pharmacoeconomics|November 14, 2009
Healthcare costs and obesity prevention: drug costs and other sector-specific consequencesDavid R Rappange, Werner B F Brouwer, Rudolf T Hoogenveen, et al.
Pharmacoeconomics|November 6, 2009
Barriers to generalizability of health economic evaluations in Latin America and the Caribbean regionFederico Augustovski, Cynthia Iglesias, Andrea Manca, et al.
Pharmacoeconomics|November 6, 2009
Cost effectiveness of facility-based care, home-based care and mobile clinics for provision of antiretroviral therapy in UgandaJoseph B Babigumira, Ajay K Sethi, Kathleen A Smyth, et al.
Pharmacoeconomics|November 10, 2005
Economic evaluation of three two-drug chemotherapy regimens in advanced non-small-cell lung cancerNiels Neymark, Pilar Lianes, Egbert F Smit, et al.
Pharmacoeconomics|September 13, 2014
Eribulin for the treatment of advanced or metastatic breast cancer: a NICE single technology appraisalJanette Greenhalgh, Adrian Bagust, Angela Boland, et al.
Pharmacoeconomics|October 21, 2017
Recommended Methods for the Collection of Health State Utility Value Evidence in Clinical StudiesRoberta Ara, John Brazier, Tracey Young
Pageof 335